DNX VENTURE PARTNERS IV
DNX VENTURE PARTNERS IV is a Seed, Series A, Series B and Series C+ fund in the US, Asia, China and Japan writing $1M–$5M checks into AI, Enterprise, Fintech, healthcare-tech and industrial-tech.
- Stages
- Seed, Series A, Series B, Series C+
- Sectors
- AI, Enterprise, Fintech, healthcare-tech, industrial-tech
- Check size
- $1M–$5M
- Invests in
- US-wide, Asia, China, Japan
- Actively investing
- Yes
- Founded
- 2014
- Assets under management
- $750M+
- Website
- dnx.vc
Thesis
DNX Venture Partners IV is a venture capital firm founded in 2014, specializing in cross-border B2B technology startups with a focus on the US-China connection. They target Seed, Series A, and Series B rounds, with occasional Series C participation, in sectors like enterprise software, AI, fintech, digital health, and industrial technology. The firm operates with offices in Palo Alto and Shanghai, leveraging dual-platform expertise to support global expansion from inception. DNX typically leads or co-leads investments and takes board seats. While specific AUM for Fund IV isn't public, DNX Ventures manages over $750 million across multiple funds. Their typical investment ranges from $1 million to $5 million per company at the Seed and Series A stages. They also back teams operating primarily in North America or Asia and have a presence in Japan.
Common questions
Does DNX VENTURE PARTNERS IV invest at the Seed stage?
Yes. DNX VENTURE PARTNERS IV lists Seed, Series A, Series B and Series C+ among the stages it invests in.
What check size does DNX VENTURE PARTNERS IV write?
DNX VENTURE PARTNERS IV writes $1M–$5M checks.
Where does DNX VENTURE PARTNERS IV invest?
DNX VENTURE PARTNERS IV invests in the US, Asia, China and Japan.